Biogen Lowers 2023 Earnings Guidance on Costs of Reata Purchase

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Business News News

Business Business Latest News,Business Business Headlines

Biogen Inc. lowered its full-year earnings guidance on acquisition-related costs and predicted a smaller dip in sales after quarterly revenue beat analysts’ expectations.

UBS Begins Sale of First AT1 Bond Since Credit Suisse CollapseSigna Appoints Restructuring Expert Geiwitz to Lead TurnaroundAsia Stocks to Open Mixed After S&P Extends Rally: Markets WrapRussia to Keep Grain Export Quota High After Another Bumper CropMarkets today: Global shares mostly slip ahead of speech by Fed's PowellChina Is Having a Hard Time Wooing Foreign Investors BackWhy Those Bank Emissions Numbers Are So RosyKenya Currency Falls After Fitch WarningOttawa extends deadline for...

counterparts: TMU studyFinancial planning for raising kids: expert says cash flow is keyFinancial stress levels climb as Canadians use debt to pay for essentialsEmployers set aside less for 2024 pay increases: surveyBank of Canada rate pause opens sweet spot for savers: Dale JacksonUS 30-Year Mortgage Rate Tumbles by Most in More Than a YearPing An Exited Its Country Garden Stake, Has No Takeover PlanM&S Brings Back Dividend After Four Years as Profit SoarsWorld’s Most Expensive City to...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in BUSİNESS

Business Business Latest News, Business Business Headlines